Ophthalmic injection of viscous formulations – why unique needs require a novel delivery approach

Shetty G, Whelton R, ONdrugDelivery, Issue 130 (Mar 2022), pp 54–58.

Congruence Medical Solutions designs, develops and supplies device platforms that optimise the potential of injectable drugs with emerging and hard-to address delivery needs. It offers solutions for microlitre dosing, viscous drug delivery, multi-dosing, variable dosing and minimising drug waste.

“The main drivers behind this trend are similar to those observed in parenteral delivery, including more long-acting drugs, high-strength formulations and bi-specific antibody drugs, as well as the need to store injectables at a low temperature.”

Read the full article at ONdrugDelivery